+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Forecast 2024-2030- Product Image
Global Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Forecast 2024-2030- Product Image
Sale

Global Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337233
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Microbiology Market size was estimated at USD 7.80 billion in 2023, USD 8.68 billion in 2024, and is expected to grow at a CAGR of 10.91% to reach USD 16.12 billion by 2030.

Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of organisms and methods used to isolate & identify them. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology.

Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancement in clinical microbiology instruments and processes presents various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

Regional Insights

In North America, the strong presence of leading market players, increasing investments in research & development, and the growing prevalence of infectious diseases significantly increase the adoption of clinical microbiology. Highly developed pharmaceutical and healthcare sectors in the United States are fueling the adoption of advanced clinical diagnostic techniques. Developing new and innovative microbiological technologies, such as targeted polymerase chain reactions (PCRs), to increase cost-effectiveness and improve clinical outcomes is strengthening the market growth of clinical microbiology across the region.

In Asia-Pacific, the growing popularity of broad-range and molecular diagnosis to surge the sensitivity of diagnosis while promoting time effectiveness significantly contributes to the development of clinical microbiology. The booming medical tourism industry is expected to increase the need for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. In the Europe region, the increasing prevalence of pathogenic diseases, growth in the discovery of adapting bacterium, and the rising need for speedy microbiological testing methods enhance the utilization of clinical microbiology technology.

Market Trends by Segment

  • Product: Use of laboratory instruments in clinical microbiology assessments
  • Specimen Type: Preference for serum samples in serological testing to detect past or current infections
  • End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
  • Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Wichita State’s MDL Lab Shifting To Microbiology.

Wichita State University's Microbial Detection Laboratory (MDL) is set to shift its focus toward clinical microbiology to meet the growing demands of the healthcare industry. This new direction aligns with the MDL's core competencies, which includes the identification and control of microbial contaminants in food, water, and air. By expanding its expertise in clinical microbiology, the MDL is able to provide comprehensive testing and diagnostics for infectious diseases, in addition to its existing services. The laboratory's commitment to quality and precision sets it apart from others in the industry, making it a go-to resource for healthcare providers in need of reliable and efficient testing. This new development is a testament to the MDL's adaptability and commitment.

Cambridge Start-Up Won Funding To Develop New Diagnostics.

A Cambridge-based start-up company secured funding to develop advanced diagnostic tools for clinical microbiology. With the aim of revolutionizing the way bacterial infections are diagnosed and treated, the team of scientists and engineers at this innovative start-up are working toward creating a range of rapid and accurate tests that can identify and characterize infections in a few hours. With the potential to significantly improve patient outcomes and reduce the spread of antibiotic-resistant strains of bacteria, this development marks an exciting breakthrough for the field of clinical microbiology.

Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore

The Microbiology Society and the Indian Institute of Science (IISc) Bangalore have recently announced a groundbreaking Publish and Read agreement to enable open-access publishing to microbiologists worldwide, promoting knowledge sharing and enhancing researcher visibility and reputation.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux S.A., Cardinal Health, Inc., Clinichem Ltd., COPAN Diagnostics Inc., Diagnóstica Longwood S.L., ELITech Group, F. Hoffmann-La Roche Ltd., Hardy Diagnostics, HORIBA, Ltd., Kyokuto Pharmaceutical Industrial Co., Ltd., Laboratorios Conda, S.A., Liofilchem S.r.l., Merck KGaA, Prestige Diagnostics U.K. Ltd., Pro Lab Diagnostics Inc., QIAGEN N.V., Rapid Micro Biosystems, Inc., Shimadzu Corporation, SSI Diagnostica A/S, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Vircell S.L.

This research report offers invaluable insights into various crucial aspects of the Clinical Microbiology Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
5.1.3. Opportunities
5.1.3.1. Technological advancement in clinical microbiology products and processes
5.1.3.2. Introduction of point-of-care microbiology testing
5.1.4. Challenges
5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
5.2. Market Segmentation Analysis
5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
5.3. Market Trend Analysis
5.3.1. Presence of well-established market vendors with the ongoing development of advanced clinical microbiology testings
5.3.2. Prevalence of infectious disease and improvements in clinical microbiology products in APAC
5.3.3. Supportive government initiatives and ongoing research to overcome the burden of infectious diseases in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Clinical Microbiology Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
7. Clinical Microbiology Market, by Specimen Type
7.1. Introduction
7.2. Blood
7.3. Body fluids
7.4. Cerebrospinal Spinal Fluid
7.5. Fecal
7.6. Saliva
7.7. Serum
7.8. Synovial Fluid
7.9. Urine
8. Clinical Microbiology Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Care Providers
8.4. Laboratories
9. Clinical Microbiology Market, by Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Cardiology
9.4. Diabetes
9.5. Drug Testing
9.6. Gastrointestinal Diseases
9.7. Nephrology
9.8. Oncology
9.9. Periodontal Diseases
9.10. Respiratory Diseases
9.11. Sexually Transmitted Diseases
10. Americas Clinical Microbiology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Microbiology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Clinical Microbiology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Wichita State’s MDL Lab Shifting To Microbiology.
13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomérieux to Optimize Laboratory Workflow and Improve Patient Care.
13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
13.3.13. Federal Funds Set To Boost U of A’s Ability To Handle Highly Infectious Pathogens.
13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
13.3.15. Sci-Tech Daresbury’s Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
13.3.24. bioMérieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 90. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 91. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 98. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 99. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 134. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 135. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 150. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 151. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 158. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 159. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 166. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 167. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 174. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 175. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 182. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 183. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 190. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 191. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 198. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 199. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 206. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 207. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 214. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 215. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 229. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 232. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 233. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 240. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 241. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 248. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 249. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 256. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 257. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 264. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 265. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 272. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 273. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 280. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 281. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 288. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 289. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 296. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 297. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 304. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 305. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 306. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 307. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 310. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 311. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 312. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 313. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 318. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 319. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 320. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 321. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 324. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 325. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 326. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 327. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 328. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 329. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 336. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 342. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
TABLE 344. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA CLINICAL MICROBIOLOGY

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Advanced Instruments, LLC
  • Agilent Technologies, Inc.
  • B. Braun SE
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Cardinal Health, Inc.
  • Clinichem Ltd.
  • COPAN Diagnostics Inc.
  • Diagnóstica Longwood S.L.
  • ELITech Group
  • F. Hoffmann-La Roche Ltd.
  • Hardy Diagnostics
  • HORIBA, Ltd.
  • Kyokuto Pharmaceutical Industrial Co., Ltd.
  • Laboratorios Conda, S.A.
  • Liofilchem S.r.l.
  • Merck KGaA
  • Prestige Diagnostics U.K. Ltd.
  • Pro Lab Diagnostics Inc.
  • QIAGEN N.V.
  • Rapid Micro Biosystems, Inc.
  • Shimadzu Corporation
  • SSI Diagnostica A/S
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.
  • Vircell S.L.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.12 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Global Clinical Microbiology Market Size, Share & Trends Analysis Report by Product (Laboratory Instruments, Reagents), Disease (STDs, Respiratory Diseases), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Clinical Microbiology Market Size, Share & Trends Analysis Report by Product (Laboratory Instruments, Reagents), Disease (STDs, Respiratory Diseases), Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Clinical Microbiology Global Market Report 2024 - Product Image

Clinical Microbiology Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Clinical Microbiology Instruments and Reagents - Global Strategic Business Report - Product Image

Clinical Microbiology Instruments and Reagents - Global Strategic Business Report

  • Report
  • 664 Pages
  • Global
From
Clinical Microbiology Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Clinical Microbiology Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 91 Pages
  • Global
From
Global In-Vitro Diagnostics Instrument Market by Product (Clinical Microbiology, Hematology, Hemostasis), End User (Academic & Research Institutes, Homecare, Hospitals & Diagnostic Laboratories) - Forecast 2024-2030 - Product Image

Global In-Vitro Diagnostics Instrument Market by Product (Clinical Microbiology, Hematology, Hemostasis), End User (Academic & Research Institutes, Homecare, Hospitals & Diagnostic Laboratories) - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From

About the Clinical Microbiology Market

The Clinical Microbiology market within the In Vitro Diagnostics (IVD) sector is a rapidly growing field. It is focused on the development and production of diagnostic tests and instruments used to detect and identify microorganisms, such as bacteria, viruses, fungi, and parasites. These tests are used to diagnose and monitor infectious diseases, as well as to detect and monitor antibiotic resistance. Clinical Microbiology tests are used in a variety of settings, including hospitals, laboratories, and point-of-care settings. The Clinical Microbiology market is driven by the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for rapid and accurate diagnosis. Additionally, the increasing demand for personalized medicine and the development of new technologies are expected to drive the market in the future. Some of the major companies in the Clinical Microbiology market include Abbott Laboratories, Becton Dickinson, bioMérieux, Cepheid, Danaher Corporation, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.